《Table 2:Placebo effect on HbA1c changes in the antidiabetic treatment between Asian and Caucasian p

  提示：宽带有限、当前游客访问压缩模式

本系列图表出处文件名：随高清版一同展现

《亚洲与欧美人群2型糖尿病患者的安慰剂效应比较（英文）》

1. 获取 高清版本忘记账户？点击这里登录

1. 下载图表忘记账户？点击这里登录

Moreover，there were eight studies in Asian population and 33 studies in Caucasian population with GLP?1RAtreatment compared with placebo[Supplementary Tables S1 and S2].Baseline characteristics of the patients received placebo treatment in different studies are shown in Table 1.Baseline BMI was significantly different between Asian and Caucasians in the treatment of AGIs，TZDs，DPP?4i，SGLT2i，and GLP?1RAs，but not in the treatment of MET.Other characteristics such as baseline age，gender，duration of diabetes，and baseline HbA1c were comparable between Asian and Caucasian populations in most kinds of antidiabetic treatment.